![Peter E. Grebow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter E. Grebow
Gründer bei P. E. Grebow Consulting, Inc.
Aktive Positionen von Peter E. Grebow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Q Therapeutics, Inc.
![]() Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Direktor/Vorstandsmitglied | 06.12.2011 | - |
P. E. Grebow Consulting, Inc. | Gründer | 01.01.2011 | - |
Präsident | 01.01.2011 | - | |
MAGiQ Therapeutics, Inc.
![]() MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Peter E. Grebow
Ehemalige bekannte Positionen von Peter E. Grebow
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
REBUS HOLDINGS, INC. | Direktor/Vorstandsmitglied | 31.05.2012 | 22.03.2016 |
Vorsitzender | 22.03.2016 | 09.02.2018 | |
Independent Dir/Board Member | 31.05.2012 | 09.02.2018 | |
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Direktor/Vorstandsmitglied | 23.02.2009 | 24.10.2013 |
Independent Dir/Board Member | 03.11.2011 | 24.10.2013 | |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01.04.2010 | 01.04.2010 |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01.01.1990 | 01.01.1990 |
EAGLE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2013 | - |
Corporate Officer/Principal | 01.10.2013 | - | |
Complexa, Inc.
![]() Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Direktor/Vorstandsmitglied | 01.01.2011 | - |
Ausbildung von Peter E. Grebow
University of California, Santa Barbara | Doctorate Degree |
Cornell University | Undergraduate Degree |
Rutgers State University of New Jersey | Graduate Degree |
Statistik
International
Vereinigte Staaten | 11 |
Frankreich | 2 |
Kanada | 2 |
Operativ
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sektoral
Health Technology | 8 |
Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
REBUS HOLDINGS, INC. | Health Technology |
EAGLE PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 7 |
---|---|
Optimer Pharmaceuticals LLC
![]() Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
Cephalon, Inc.
![]() Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Q Therapeutics, Inc.
![]() Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman on March 28, 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
P. E. Grebow Consulting, Inc. | |
Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Complexa, Inc.
![]() Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
MAGiQ Therapeutics, Inc.
![]() MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Health Technology |
- Börse
- Insiders
- Peter E. Grebow
- Erfahrung